Difference between revisions of "Part:BBa K1150018"

Latest revision as of 16:53, 4 October 2013

Cas9 with SV40 promoter

pSV40:HA-NLS-dCas9-G9a-NLS:tBGH
Function	DNA binding protein
Use in	Mammalian cells
RFC standard	RFC 25
Backbone	pSB1C3
Organism	Streptococcus pyogenes
Source	Feng Zhang, Addgene
Submitted by	[http://2013.igem.org/Team:Freiburg Freiburg 2013]

Cas9 is a protein that binds DNA via an protein-RNA-DNA interaction. This version of Cas9 (dCas9) is working as a carrier for effectors that want to be brought to DNA in a sequence specific manner. The native nikase activity of the protein has been mutated so that it allows DNA binding without cutting. The sequence is human codon optimized. The protein is part of team Freiburg's (2013) the [http://2013.igem.org/Team:Freiburg uniCAS toolkit].

The usage of the medium strong SV40 promoter optimizes this device for means were a strong expression is suboptimal. If a strong expression is desired check our device with CMV promoter.

Usage and Biology

The dCas9 protein is able to target several loci at once as it interacts with small RNAs to build up a complex that will interact with complementary DNA strands. Its origin is the adaptive immune system of Streptococcus pyogenes called CRISPR. Hijacking this system leads to a whole new approach for multiple gene targeting.

The iGEM team Freiburg 2013 combined effectors with this protein to create a toolkit, that is able to activate or repress specific and multiple target loci.

This approach offers new possibilities for fundamental epigenetic research, tissue engineering and cancer research.

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
INCOMPATIBLE WITH RFC[21]
Illegal BglII site found at 664
Illegal BglII site found at 5139
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

@@ Line 30: / Line 30: @@
-Cas9 is a protein that binds DNA via an protein-RNA-DNA interaction. [https://parts.igem.org/Part:BBa_K1150000 This version of Cas9] is working as a carrier for effectors that want to be brought to DNA in a sequence specific manner. The native nikase activity of the protein has been mutated so that it allows DNA binding without cutting. The sequence is human codon optimized.
+Cas9 is a protein that binds DNA via an protein-RNA-DNA interaction. [https://parts.igem.org/Part:BBa_K1150000 This version of Cas9] (dCas9) is working as a carrier for effectors that want to be brought to DNA in a sequence specific manner. The native nikase activity of the protein has been mutated so that it allows DNA binding without cutting. The sequence is human codon optimized.
 The protein is part of team Freiburg's (2013) the [http://2013.igem.org/Team:Freiburg uniCAS toolkit].
 The usage of the medium strong [https://parts.igem.org/Part:BBa_K1150011 SV40 promoter] optimizes this device for means were a strong expression is suboptimal. If a strong expression is desired check our [https://parts.igem.org/Part:BBa_K1150017 device with CMV promoter].
 ==Usage and Biology==
-The dCAS9 protein is able to be targeted to several loci at once as it interacts with small RNAs to build up a complex that will interact with complementary DNA strands. Its origin is the adaptive immune system of <i>Streptococcus pyogenes </i> called CRISPR. Hijacking this system leads to a whole new approach for multiple gene targeting.
+The dCas9 protein is able to target several loci at once as it interacts with small RNAs to build up a complex that will interact with complementary DNA strands. Its origin is the adaptive immune system of <i>Streptococcus pyogenes </i> called CRISPR. Hijacking this system leads to a whole new approach for multiple gene targeting.
 The iGEM team Freiburg 2013 combined effectors with this protein to create a toolkit, that is able to activate or repress specific and multiple target loci.